AngioDynamics Inc
ANGO8.620USD
+0.060+0.70%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
353.37MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über AngioDynamics Inc Unternehmen
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
Unternehmensinformationen
BörsenkürzelANGO
Name des UnternehmensAngioDynamics Inc
IPO-datumMay 27, 2004
CEOMr. James C. Clemmer
Anzahl der mitarbeiter675
WertpapierartOrdinary Share
GeschäftsjahresendeMay 27
Addresse14 Plaza Drive
StadtLATHAM
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl12110
Telefon15187981215
Websitehttps://www.angiodynamics.com/
BörsenkürzelANGO
IPO-datumMay 27, 2004
CEOMr. James C. Clemmer
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
342.85K
+31.96%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
+11.83%
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
138.76K
+23.88%
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
+15.78%
Mr. Warren G. Nighan
Mr. Warren G. Nighan
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
--
--
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Independent Director
Independent Director
--
--
Ms. Karen A. Licitra
Ms. Karen A. Licitra
Independent Director
Independent Director
--
--
Ms. Lorinda A. Burgess
Ms. Lorinda A. Burgess
Independent Director
Independent Director
--
--
Mr. James C. Clemmer
Mr. James C. Clemmer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
342.85K
+31.96%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
+11.83%
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
138.76K
+23.88%
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
+15.78%
Mr. Warren G. Nighan
Mr. Warren G. Nighan
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
--
--
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
United States
61.34M
85.19%
International
10.66M
14.81%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Sat, May 17
Aktualisiert: Sat, May 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
7.53%
Systematic Financial Management, L.P.
6.15%
The Vanguard Group, Inc.
6.13%
Millennium Management LLC
5.28%
Divisadero Street Capital Management, LP
5.26%
Other
69.65%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
7.53%
Systematic Financial Management, L.P.
6.15%
The Vanguard Group, Inc.
6.13%
Millennium Management LLC
5.28%
Divisadero Street Capital Management, LP
5.26%
Other
69.65%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
35.57%
Investment Advisor/Hedge Fund
31.53%
Hedge Fund
20.99%
Individual Investor
6.84%
Research Firm
3.21%
Pension Fund
1.56%
Private Equity
0.88%
Bank and Trust
0.25%
Insurance Company
0.03%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
376
39.73M
97.80%
-5.84M
2025Q1
387
38.84M
95.70%
-6.48M
2024Q4
375
36.32M
89.71%
-5.96M
2024Q3
384
35.71M
87.94%
-11.00M
2024Q2
382
35.41M
88.44%
-13.81M
2024Q1
384
38.17M
95.80%
-10.29M
2023Q4
394
39.11M
98.18%
-8.70M
2023Q3
380
38.76M
97.39%
-7.29M
2023Q2
379
38.85M
99.01%
-7.43M
2023Q1
376
39.36M
100.34%
-6.61M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
3.06M
7.53%
-175.89K
-5.44%
Mar 31, 2025
Systematic Financial Management, L.P.
2.50M
6.15%
-23.78K
-0.94%
Mar 31, 2025
The Vanguard Group, Inc.
2.49M
6.14%
+199.94K
+8.72%
Mar 31, 2025
Millennium Management LLC
1.24M
3.05%
-923.00K
-42.68%
Mar 31, 2025
Divisadero Street Capital Management, LP
2.14M
5.26%
+1.18M
+122.60%
Jun 02, 2025
Armistice Capital LLC
2.09M
5.16%
+1.22M
+140.14%
Mar 31, 2025
Segall Bryant & Hamill, LLC
1.38M
3.41%
-30.72K
-2.17%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
1.17M
2.87%
-323.10K
-21.70%
Mar 31, 2025
Nuveen LLC
1.15M
2.83%
-145.78K
-11.26%
Mar 31, 2025
Clemmer James C
929.61K
2.29%
+20.00K
+2.20%
Oct 07, 2024
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Name
Anteil
SPDR S&P Health Care Equipment ETF
0.52%
Invesco NASDAQ Future Gen 200 ETF
0.44%
Vanguard US Multifactor ETF
0.14%
Vanguard US Momentum Factor ETF
0.12%
iShares Micro-Cap ETF
0.09%
Vanguard US Quality Factor ETF
0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.07%
Invesco Russell 2000 Dynamic Multifactor ETF
0.06%
Avantis US Small Cap Equity ETF
0.05%
Fidelity Enhanced Small Cap ETF
0.04%
Mehr Anzeigen
SPDR S&P Health Care Equipment ETF
Anteil0.52%
Invesco NASDAQ Future Gen 200 ETF
Anteil0.44%
Vanguard US Multifactor ETF
Anteil0.14%
Vanguard US Momentum Factor ETF
Anteil0.12%
iShares Micro-Cap ETF
Anteil0.09%
Vanguard US Quality Factor ETF
Anteil0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0.07%
Invesco Russell 2000 Dynamic Multifactor ETF
Anteil0.06%
Avantis US Small Cap Equity ETF
Anteil0.05%
Fidelity Enhanced Small Cap ETF
Anteil0.04%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
